Review



islet microvascular endothelial cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC islet microvascular endothelial cell line
    Stromelysin‐1 KO promotes IMEC proliferation and confers resistance to glucotoxicity. (A) Validation of stromelysin‐1 knockout. Representative immunoblot and corresponding densitometric quantification showing the depletion of stromelysin‐1 protein in knockout (KO) IMECs compared to wild‐type (WT) controls. (B) Quantification of IMEC proliferation, assessed by phase object confluence over 72 h. WT and stromelysin‐1 KO cells were cultured under normal glucose (Control, 5.6 mM), high glucose (HG, 35 mM), and HG supplemented with 10 −8 M insulin (HG + I), 0.5 mM l ‐arginine (HG + LA), or 100 μM β‐mercaptoethanol (HG + βME). Representative images at 72 h are shown. Scale bar = 100 μm. (C) Quantitative analysis of cell proliferation measured as the percentage of phase object confluence. WT, wild‐type. KO, knockout. IMECs, islet <t>microvascular</t> <t>endothelial</t> cells. Data are presented as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the corresponding WT group under the same treatment conditions.
    Islet Microvascular Endothelial Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 581 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/islet+microvascular+endothelial+cell+line/MS1/pmc13097633-49-2-8
    Average 96 stars, based on 581 article reviews
    islet microvascular endothelial cell line - by Bioz Stars, 2026-09
    96/100 stars

    Images

    1) Product Images from "Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells"

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells

    Journal: Journal of Cellular and Molecular Medicine

    doi: 10.1111/jcmm.71098

    Stromelysin‐1 KO promotes IMEC proliferation and confers resistance to glucotoxicity. (A) Validation of stromelysin‐1 knockout. Representative immunoblot and corresponding densitometric quantification showing the depletion of stromelysin‐1 protein in knockout (KO) IMECs compared to wild‐type (WT) controls. (B) Quantification of IMEC proliferation, assessed by phase object confluence over 72 h. WT and stromelysin‐1 KO cells were cultured under normal glucose (Control, 5.6 mM), high glucose (HG, 35 mM), and HG supplemented with 10 −8 M insulin (HG + I), 0.5 mM l ‐arginine (HG + LA), or 100 μM β‐mercaptoethanol (HG + βME). Representative images at 72 h are shown. Scale bar = 100 μm. (C) Quantitative analysis of cell proliferation measured as the percentage of phase object confluence. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are presented as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the corresponding WT group under the same treatment conditions.
    Figure Legend Snippet: Stromelysin‐1 KO promotes IMEC proliferation and confers resistance to glucotoxicity. (A) Validation of stromelysin‐1 knockout. Representative immunoblot and corresponding densitometric quantification showing the depletion of stromelysin‐1 protein in knockout (KO) IMECs compared to wild‐type (WT) controls. (B) Quantification of IMEC proliferation, assessed by phase object confluence over 72 h. WT and stromelysin‐1 KO cells were cultured under normal glucose (Control, 5.6 mM), high glucose (HG, 35 mM), and HG supplemented with 10 −8 M insulin (HG + I), 0.5 mM l ‐arginine (HG + LA), or 100 μM β‐mercaptoethanol (HG + βME). Representative images at 72 h are shown. Scale bar = 100 μm. (C) Quantitative analysis of cell proliferation measured as the percentage of phase object confluence. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are presented as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the corresponding WT group under the same treatment conditions.

    Techniques Used: Biomarker Discovery, Knock-Out, Western Blot, Cell Culture, Control

    Stromelysin‐1 KO enhances the migratory capacity of IMECs in a wound healing assay. (A) Representative images of a scratch wound healing assay at 0, 24, and 48 h. WT and stromelysin‐1 KO IMECs were subjected to Control (5.6 mM glucose), HG (35 mM glucose), HG + I (insulin, 10 −8 M), HG + LA ( l ‐arginine, 0.5 mM), and HG + βME (β‐mercaptoethanol, 100 μM), respectively. Scale bar = 100 μm. (B) Quantification of wound closure, presented as relative wound confluence at 24 and 48 h. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are presented as mean ± SEM from three independent experiments. * p < 0.05, ** p < 0.01, *** p ＜0.001, **** p < 0.0001 compared with the corresponding WT group.
    Figure Legend Snippet: Stromelysin‐1 KO enhances the migratory capacity of IMECs in a wound healing assay. (A) Representative images of a scratch wound healing assay at 0, 24, and 48 h. WT and stromelysin‐1 KO IMECs were subjected to Control (5.6 mM glucose), HG (35 mM glucose), HG + I (insulin, 10 −8 M), HG + LA ( l ‐arginine, 0.5 mM), and HG + βME (β‐mercaptoethanol, 100 μM), respectively. Scale bar = 100 μm. (B) Quantification of wound closure, presented as relative wound confluence at 24 and 48 h. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are presented as mean ± SEM from three independent experiments. * p < 0.05, ** p < 0.01, *** p ＜0.001, **** p < 0.0001 compared with the corresponding WT group.

    Techniques Used: Wound Healing Assay, Control, Knock-Out

    Stromelysin‐1 KO restores endothelial barrier integrity and attenuates glucotoxicity‐induced hyperpermeability. (A) Experimental groups and treatment conditions. (B) Schematic of the transwell‐based permeability assay. Confluent IMEC monolayers were exposed to the treatment media for 24 h, and the passage of 2 mg/mL FITC‐dextran from the upper to the lower chamber was measured over time. (C) Quantification of FITC‐dextran flux across IMEC monolayers over 90 min. Data show fluorescence intensity in the lower chamber, normalised to the baseline at t = 0. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Control (5.6 mM glucose), HG (35 mM glucose), HG + I (insulin, 10 −8 M), HG + LA ( l ‐arginine, 0.5 mM), and HG + βME (100 μM). Data are expressed as mean ± SEM, n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, compared with corresponding WT group.
    Figure Legend Snippet: Stromelysin‐1 KO restores endothelial barrier integrity and attenuates glucotoxicity‐induced hyperpermeability. (A) Experimental groups and treatment conditions. (B) Schematic of the transwell‐based permeability assay. Confluent IMEC monolayers were exposed to the treatment media for 24 h, and the passage of 2 mg/mL FITC‐dextran from the upper to the lower chamber was measured over time. (C) Quantification of FITC‐dextran flux across IMEC monolayers over 90 min. Data show fluorescence intensity in the lower chamber, normalised to the baseline at t = 0. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Control (5.6 mM glucose), HG (35 mM glucose), HG + I (insulin, 10 −8 M), HG + LA ( l ‐arginine, 0.5 mM), and HG + βME (100 μM). Data are expressed as mean ± SEM, n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, compared with corresponding WT group.

    Techniques Used: Permeability, Fluorescence, Knock-Out, Control

    Stromelysin‐1 KO remodels the secretome of IMECs towards a pro‐stabilisation profile. (A) Representative cytokine array membranes comparing the secretomes of WT and stromelysin‐1 KO IMECs under 5.6 mM glucose (Control), 35 mM glucose (HG), 35 mM glucose plus 10 −8 M insulin (HG + I), 35 mM glucose plus 0.5 mM l ‐arginine (HG + LA) and 35 mM glucose plus 100 μM β‐mercaptoethanol (HG + βME). Black boxes highlight proteins with significant differential expression. Reference spots were used for signal normalisation. (B) Densitometric quantification of differentially secreted proteins. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are expressed as mean ± SEM, n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 compared with corresponding WT IMECs.
    Figure Legend Snippet: Stromelysin‐1 KO remodels the secretome of IMECs towards a pro‐stabilisation profile. (A) Representative cytokine array membranes comparing the secretomes of WT and stromelysin‐1 KO IMECs under 5.6 mM glucose (Control), 35 mM glucose (HG), 35 mM glucose plus 10 −8 M insulin (HG + I), 35 mM glucose plus 0.5 mM l ‐arginine (HG + LA) and 35 mM glucose plus 100 μM β‐mercaptoethanol (HG + βME). Black boxes highlight proteins with significant differential expression. Reference spots were used for signal normalisation. (B) Densitometric quantification of differentially secreted proteins. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are expressed as mean ± SEM, n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 compared with corresponding WT IMECs.

    Techniques Used: Control, Quantitative Proteomics, Knock-Out

    Related Articles

    Biomarker Discovery:

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.. The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.

    Knock-Out:

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.. The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.

    Western Blot:

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.. The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.

    Cell Culture:

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.. The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.

    Control:

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.. The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.

    Wound Healing Assay:

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.. The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.

    Permeability:

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.. The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.

    Fluorescence:

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.. The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.

    Quantitative Proteomics:

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells
    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.. The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.The basal medium consisted of Dulbecco's Modified Eagle Medium (DMEM) containing 5.6 mM glucose, supplemented with 10% fetal bovine serum (FBS), 2% HEPES (Gibco, Carlsbad, CA, USA), and a 1% penicillin–streptomycin solution (containing 100 U/mL penicillin and 100 μg/mL streptomycin) to maintain cell viability and prevent microbial contamination.



    Similar Products

    islet microvascular endothelial cell line  (ATCC)
    96
    ATCC islet microvascular endothelial cell line
    Stromelysin‐1 KO promotes IMEC proliferation and confers resistance to glucotoxicity. (A) Validation of stromelysin‐1 knockout. Representative immunoblot and corresponding densitometric quantification showing the depletion of stromelysin‐1 protein in knockout (KO) IMECs compared to wild‐type (WT) controls. (B) Quantification of IMEC proliferation, assessed by phase object confluence over 72 h. WT and stromelysin‐1 KO cells were cultured under normal glucose (Control, 5.6 mM), high glucose (HG, 35 mM), and HG supplemented with 10 −8 M insulin (HG + I), 0.5 mM l ‐arginine (HG + LA), or 100 μM β‐mercaptoethanol (HG + βME). Representative images at 72 h are shown. Scale bar = 100 μm. (C) Quantitative analysis of cell proliferation measured as the percentage of phase object confluence. WT, wild‐type. KO, knockout. IMECs, islet <t>microvascular</t> <t>endothelial</t> cells. Data are presented as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the corresponding WT group under the same treatment conditions.
    Islet Microvascular Endothelial Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/islet+microvascular+endothelial+cell+line/MS1/pmc13097633-49-2-8
    Average 96 stars, based on 1 article reviews
    islet microvascular endothelial cell line - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Stromelysin‐1 KO promotes IMEC proliferation and confers resistance to glucotoxicity. (A) Validation of stromelysin‐1 knockout. Representative immunoblot and corresponding densitometric quantification showing the depletion of stromelysin‐1 protein in knockout (KO) IMECs compared to wild‐type (WT) controls. (B) Quantification of IMEC proliferation, assessed by phase object confluence over 72 h. WT and stromelysin‐1 KO cells were cultured under normal glucose (Control, 5.6 mM), high glucose (HG, 35 mM), and HG supplemented with 10 −8 M insulin (HG + I), 0.5 mM l ‐arginine (HG + LA), or 100 μM β‐mercaptoethanol (HG + βME). Representative images at 72 h are shown. Scale bar = 100 μm. (C) Quantitative analysis of cell proliferation measured as the percentage of phase object confluence. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are presented as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the corresponding WT group under the same treatment conditions.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells

    doi: 10.1111/jcmm.71098

    Figure Lengend Snippet: Stromelysin‐1 KO promotes IMEC proliferation and confers resistance to glucotoxicity. (A) Validation of stromelysin‐1 knockout. Representative immunoblot and corresponding densitometric quantification showing the depletion of stromelysin‐1 protein in knockout (KO) IMECs compared to wild‐type (WT) controls. (B) Quantification of IMEC proliferation, assessed by phase object confluence over 72 h. WT and stromelysin‐1 KO cells were cultured under normal glucose (Control, 5.6 mM), high glucose (HG, 35 mM), and HG supplemented with 10 −8 M insulin (HG + I), 0.5 mM l ‐arginine (HG + LA), or 100 μM β‐mercaptoethanol (HG + βME). Representative images at 72 h are shown. Scale bar = 100 μm. (C) Quantitative analysis of cell proliferation measured as the percentage of phase object confluence. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are presented as mean ± SEM ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the corresponding WT group under the same treatment conditions.

    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.

    Techniques: Biomarker Discovery, Knock-Out, Western Blot, Cell Culture, Control

    Stromelysin‐1 KO enhances the migratory capacity of IMECs in a wound healing assay. (A) Representative images of a scratch wound healing assay at 0, 24, and 48 h. WT and stromelysin‐1 KO IMECs were subjected to Control (5.6 mM glucose), HG (35 mM glucose), HG + I (insulin, 10 −8 M), HG + LA ( l ‐arginine, 0.5 mM), and HG + βME (β‐mercaptoethanol, 100 μM), respectively. Scale bar = 100 μm. (B) Quantification of wound closure, presented as relative wound confluence at 24 and 48 h. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are presented as mean ± SEM from three independent experiments. * p < 0.05, ** p < 0.01, *** p ＜0.001, **** p < 0.0001 compared with the corresponding WT group.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells

    doi: 10.1111/jcmm.71098

    Figure Lengend Snippet: Stromelysin‐1 KO enhances the migratory capacity of IMECs in a wound healing assay. (A) Representative images of a scratch wound healing assay at 0, 24, and 48 h. WT and stromelysin‐1 KO IMECs were subjected to Control (5.6 mM glucose), HG (35 mM glucose), HG + I (insulin, 10 −8 M), HG + LA ( l ‐arginine, 0.5 mM), and HG + βME (β‐mercaptoethanol, 100 μM), respectively. Scale bar = 100 μm. (B) Quantification of wound closure, presented as relative wound confluence at 24 and 48 h. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are presented as mean ± SEM from three independent experiments. * p < 0.05, ** p < 0.01, *** p ＜0.001, **** p < 0.0001 compared with the corresponding WT group.

    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.

    Techniques: Wound Healing Assay, Control, Knock-Out

    Stromelysin‐1 KO restores endothelial barrier integrity and attenuates glucotoxicity‐induced hyperpermeability. (A) Experimental groups and treatment conditions. (B) Schematic of the transwell‐based permeability assay. Confluent IMEC monolayers were exposed to the treatment media for 24 h, and the passage of 2 mg/mL FITC‐dextran from the upper to the lower chamber was measured over time. (C) Quantification of FITC‐dextran flux across IMEC monolayers over 90 min. Data show fluorescence intensity in the lower chamber, normalised to the baseline at t = 0. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Control (5.6 mM glucose), HG (35 mM glucose), HG + I (insulin, 10 −8 M), HG + LA ( l ‐arginine, 0.5 mM), and HG + βME (100 μM). Data are expressed as mean ± SEM, n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, compared with corresponding WT group.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells

    doi: 10.1111/jcmm.71098

    Figure Lengend Snippet: Stromelysin‐1 KO restores endothelial barrier integrity and attenuates glucotoxicity‐induced hyperpermeability. (A) Experimental groups and treatment conditions. (B) Schematic of the transwell‐based permeability assay. Confluent IMEC monolayers were exposed to the treatment media for 24 h, and the passage of 2 mg/mL FITC‐dextran from the upper to the lower chamber was measured over time. (C) Quantification of FITC‐dextran flux across IMEC monolayers over 90 min. Data show fluorescence intensity in the lower chamber, normalised to the baseline at t = 0. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Control (5.6 mM glucose), HG (35 mM glucose), HG + I (insulin, 10 −8 M), HG + LA ( l ‐arginine, 0.5 mM), and HG + βME (100 μM). Data are expressed as mean ± SEM, n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, compared with corresponding WT group.

    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.

    Techniques: Permeability, Fluorescence, Knock-Out, Control

    Stromelysin‐1 KO remodels the secretome of IMECs towards a pro‐stabilisation profile. (A) Representative cytokine array membranes comparing the secretomes of WT and stromelysin‐1 KO IMECs under 5.6 mM glucose (Control), 35 mM glucose (HG), 35 mM glucose plus 10 −8 M insulin (HG + I), 35 mM glucose plus 0.5 mM l ‐arginine (HG + LA) and 35 mM glucose plus 100 μM β‐mercaptoethanol (HG + βME). Black boxes highlight proteins with significant differential expression. Reference spots were used for signal normalisation. (B) Densitometric quantification of differentially secreted proteins. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are expressed as mean ± SEM, n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 compared with corresponding WT IMECs.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: Consequences of CRISPR ‐Cas9‐Mediated Stromelysin‐1 Knockout in Pancreatic Islet Microvascular Endothelial Cells

    doi: 10.1111/jcmm.71098

    Figure Lengend Snippet: Stromelysin‐1 KO remodels the secretome of IMECs towards a pro‐stabilisation profile. (A) Representative cytokine array membranes comparing the secretomes of WT and stromelysin‐1 KO IMECs under 5.6 mM glucose (Control), 35 mM glucose (HG), 35 mM glucose plus 10 −8 M insulin (HG + I), 35 mM glucose plus 0.5 mM l ‐arginine (HG + LA) and 35 mM glucose plus 100 μM β‐mercaptoethanol (HG + βME). Black boxes highlight proteins with significant differential expression. Reference spots were used for signal normalisation. (B) Densitometric quantification of differentially secreted proteins. WT, wild‐type. KO, knockout. IMECs, islet microvascular endothelial cells. Data are expressed as mean ± SEM, n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 compared with corresponding WT IMECs.

    Article Snippet: A pancreatic islet microvascular endothelial cell line (MS1; ATCC, Manassas, VA, USA) was employed in the present study, and its culture was performed in specifically formulated media.

    Techniques: Control, Quantitative Proteomics, Knock-Out